Pro-Dex Inc (PDEX)
18.12
-0.34
(-1.84%)
USD |
NASDAQ |
Apr 26, 11:13
Pro-Dex Cash from Financing (TTM): -0.864M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.864M |
September 30, 2023 | -2.935M |
June 30, 2023 | -2.49M |
March 31, 2023 | -1.897M |
December 31, 2022 | -1.898M |
September 30, 2022 | -1.272M |
June 30, 2022 | -0.79M |
March 31, 2022 | -3.299M |
December 31, 2021 | -2.89M |
September 30, 2021 | 3.073M |
June 30, 2021 | 3.088M |
March 31, 2021 | 4.061M |
December 31, 2020 | 3.255M |
September 30, 2020 | -3.51M |
June 30, 2020 | -3.979M |
March 31, 2020 | -4.879M |
December 31, 2019 | -4.246M |
September 30, 2019 | -4.159M |
June 30, 2019 | 0.45M |
March 31, 2019 | 1.71M |
December 31, 2018 | 1.935M |
September 30, 2018 | 3.615M |
June 30, 2018 | 2.002M |
March 31, 2018 | 2.246M |
December 31, 2017 | 2.132M |
Date | Value |
---|---|
September 30, 2017 | 1.928M |
June 30, 2017 | -0.298M |
March 31, 2017 | -0.789M |
December 31, 2016 | -1.139M |
September 30, 2016 | -1.007M |
June 30, 2016 | -0.457M |
March 31, 2016 | -0.008M |
December 31, 2015 | 0.399M |
September 30, 2015 | 0.297M |
June 30, 2015 | -0.203M |
March 31, 2015 | 1.317M |
December 31, 2014 | 1.415M |
September 30, 2014 | 1.509M |
June 30, 2014 | 1.514M |
March 31, 2014 | 0.017M |
December 31, 2013 | 0.013M |
September 30, 2013 | 0.065M |
June 30, 2013 | -0.709M |
March 31, 2013 | -0.819M |
December 31, 2012 | -0.908M |
September 30, 2012 | -1.048M |
June 30, 2012 | -0.363M |
March 31, 2012 | -0.359M |
December 31, 2011 | -0.216M |
September 30, 2011 | -0.199M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-4.879M
Minimum
Mar 2020
4.061M
Maximum
Mar 2021
-1.325M
Average
-1.898M
Median
Dec 2022
Cash from Financing (TTM) Benchmarks
Perspective Therapeutics Inc | 0.785M |
Retractable Technologies Inc | 0.9416M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |
Catheter Precision Inc | 8.386M |